Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Publishing timestamp: 2024-03-27 13:54:30
Summary
Study suggests that the blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even though Novo Nordisk charges almost $1000 per month for the injection in the U.S. before insurance. The study raises questions about the high price tag of top-selling diabetes treatments and similar drugs for weight loss, all part of a new class of drugs called GLP-1s. Novo Nordisk declined to provide production costs for Ozempic but stated that they spend billions on research and development and offer discounts to ensure patient access.
Sentiment: MIXED
Keywords: business news, science, novo nordisk a/s, business, health care industry, pharmaceuticals, biotechnology, biotech and pharmaceuticals,
Source: https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html